Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited engages in the production, processing, packing, and marketing of seeds in India. The company offers vegetable seeds, such as tomato, okra, bottle gourd, brinjal, carrot, cluster bean, bitter gourd, ridge gourd, cucumber, cabbage, radish, sponge gourd, pepper, chilly, sweet pepper, beet root, cow pea, corriander, onion, watermelon, musk melon, and flower seeds; cotton seed… Read more
Indo Us Bio-Tech Limited (INDOUS) - Total Liabilities
Latest total liabilities as of September 2025: ₹305.44 Million INR
Based on the latest financial reports, Indo Us Bio-Tech Limited (INDOUS) has total liabilities worth ₹305.44 Million INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Indo Us Bio-Tech Limited - Total Liabilities Trend (2022–2025)
This chart illustrates how Indo Us Bio-Tech Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Indo Us Bio-Tech Limited Competitors by Total Liabilities
The table below lists competitors of Indo Us Bio-Tech Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Porn Prom Metal Public Company Limited
BK:PPM
|
Thailand | ฿947.43 Million |
|
TEN Holdings, Inc. Common Stock
NASDAQ:XHLD
|
USA | $6.96 Million |
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
USA | $4.78 Million |
|
Desert Control AS
OL:DSRT
|
Norway | Nkr5.90 Million |
|
Blockmate Ventures Inc.
OTCQB:MATEF
|
USA | $7.26 Million |
|
International Media Acquisition Corp
NASDAQ:IMAQ
|
USA | $15.25 Million |
|
Envy Technologies Indonesia Tbk PT
JK:ENVY
|
Indonesia | Rp68.24 Billion |
|
Tajiri Resources Corp
PINK:TAJIF
|
USA | $876.34K |
Liability Composition Analysis (2022–2025)
This chart breaks down Indo Us Bio-Tech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Indo Us Bio-Tech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Indo Us Bio-Tech Limited (2022–2025)
The table below shows the annual total liabilities of Indo Us Bio-Tech Limited from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹193.24 Million | -10.99% |
| 2024-03-31 | ₹217.09 Million | +45.02% |
| 2023-03-31 | ₹149.69 Million | -12.50% |
| 2022-03-31 | ₹171.09 Million | -- |